This research report includes a detailed segmentation of the global viral conjunctivitis drugs market by route of administration (topical, oral, and intravitreal). It outlines the market shares of key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Akorn, Alcon, Allergan, and Bausch & Lomb.
Technavio’s market research analysts estimate the global viral conjunctivitis market, to grow at a CAGR of 2% between 2016 and 2020. Viral conjunctivitis or pink eye caused by viruses, and is associated with infections of the upper respiratory tract. Adenovirus and herpesvirus are commonly associated with viral conjunctivitis. Viral conjunctivitis represents up to 50% of all acute conjunctivitis in primary care, and is more prevalent among adults. Growing awareness among consumers worldwide is the primary growth driver for this market. The Americas dominate the global market, occupying around 49% of the total market share. Much of this region’s growth comes from the well-developed healthcare system, coupled with reimbursement facilities.
The new market research report from Technavio provides a breakdown and analysis of the viral conjunctivitis segments by technology.
“Owing to the unavailability of approved drugs, the market is witnessing increased use of off-label drugs, which are available at lower prices. Though the safety profiles of these drugs are not determined by the US Food and Drug Administration (FDA), they are available in the market for a number of indications. Though the efficacy of these drugs in treating the condition is low, they have better safety profile than steroids. Off-label drugs compete with branded medications, and can have a negative impact on the latter’s market share,” says Imran Mushtaq, Industry Manager, Healthcare & Lifesciences, Technavio Research
Topical drugs are most commonly used for the treatment of viral conjunctivitis. Most of these drugs are used for viral conjunctivitis such as artificial tears, NSAIDs, steroids, and antihistamine drugs in the form of eye drops because of the ease of administration.
The leading vendors in the global viral conjunctivitis market are Akorn, Alcon, Allergan, and Bausch & Lomb. The market is highly fragmented because of the presence of numerous small and large vendors. Providers in this market compete on the basis of price, quality, and innovation. The high vendor competition has led to an increased number of mergers and acquisitions, wherein smaller entities are being acquired or are being merged with major players.
A more detailed analysis is available in the Technavio report, Global Viral Conjunctivitis Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
